Fexofenadine Dosing Per Kilogram Body Weight
There is no weight-based (per kg) dosing for fexofenadine—dosing is age-based and fixed by weight categories, not calculated per kilogram.
Pediatric Dosing (Ages 6 months to 11 years)
The FDA-approved dosing for fexofenadine in children is not calculated on a per-kilogram basis. Instead, it follows fixed doses based on age groups 1:
Ages 6 to 11 years:
- 30 mg twice daily for seasonal allergic rhinitis
- 30 mg twice daily for chronic idiopathic urticaria
Ages 2 to 5 years:
- 30 mg twice daily (studied and well-tolerated) 2
Ages 6 months to 2 years:
- 15 mg twice daily or 30 mg twice daily (studied for safety) 3
- Note: Safety and effectiveness are not established by FDA for children under 6 years 1
Adolescents and Adults (Ages ≥12 years)
- Seasonal allergic rhinitis: 60 mg twice daily OR 120 mg once daily
- Chronic idiopathic urticaria: 180 mg once daily 1
Key Clinical Considerations
Important caveats:
- No per-kilogram calculation exists in FDA labeling or clinical guidelines for fexofenadine
- Dosing is determined by age categories, not weight-based formulas
- The drug was studied using fixed doses in pediatric populations, with pharmacokinetic comparisons between adults and children justifying the age-based approach 1
Administration guidance:
- Take with water only—fruit juices (grapefruit, orange, apple) reduce bioavailability by approximately 36% 1
- Avoid aluminum/magnesium-containing antacids, which reduce absorption by 41% (AUC) 1
Special populations:
- Renal impairment: No specific pediatric dose adjustment provided; adult data suggests reduced clearance in end-stage renal disease 4
- Hepatic impairment: No dose adjustment needed based on available data 1
Common pitfall: Clinicians sometimes attempt to extrapolate weight-based dosing from other antihistamines—this is inappropriate for fexofenadine, which has established fixed-dose regimens based on extensive pharmacokinetic studies showing adequate exposure and safety with age-stratified dosing 1.